Advertisement
UK markets close in 3 hours 29 minutes
  • FTSE 100

    8,094.94
    +54.56 (+0.68%)
     
  • FTSE 250

    19,716.82
    -2.55 (-0.01%)
     
  • AIM

    755.27
    +0.58 (+0.08%)
     
  • GBP/EUR

    1.1672
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2512
    +0.0049 (+0.40%)
     
  • Bitcoin GBP

    51,039.10
    -2,176.80 (-4.09%)
     
  • CMC Crypto 200

    1,358.67
    -23.90 (-1.73%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,341.80
    +3.40 (+0.15%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,970.04
    -118.66 (-0.66%)
     
  • CAC 40

    8,015.30
    -76.56 (-0.95%)
     

LV= anticipates jump in cancer claims in 2021

LV= has said it expects to see a jump in cancer claims in 2021 following screening backlogs.

The protection specialist said it recorded a 45% fall in critical illness claims in April compared with 2019 figures.

But it is anticipating a rise in advanced stage cancer diagnoses and claims in 2021, caused by a backlog of screenings.

Despite the fall in cancer claims during lockdown, LV= said that between January and July it paid more than £22.7 million in cancer claims to 412 people and their families across income protection, critical illness and life insurance.

Debbie Kennedy, director of protection at LV=, said: “Since the start of lockdown we saw a worrying fall in critical illness insurance claims as the NHS was forced to shut down or significantly reduce many areas of non-Covid care for cancer between April and June.

ADVERTISEMENT

“This, combined with fewer patients seeking care during lockdown, means that there has been a significant drop in elective procedures, urgent cancer referrals, first cancer treatments and outpatient appointments.

“There is a real risk that having fewer cancer screenings during lockdown will develop into a long-term problem, as more people are prevented from receiving a timely cancer diagnosis. By the time that these cases reach the claims stage, customers may experience more acute symptoms than in previous years which will be difficult to treat.”